Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation

Documenti analoghi

• Treating experimental arthritis with the innate immune inhibitor interleukin-37 reduces joint and systemic inflammation
  di: Cavalli, Giulio, et al.
  Pubblicazione: (2016)
• Interleukin 37 reverses the metabolic cost of inflammation, increases oxidative respiration, and improves exercise tolerance
  di: Cavalli, Giulio, et al.
  Pubblicazione: (2017)
• Suppression of Innate Inflammation and Immunity by Interleukin Family Member Interleukin-37
  di: Dinarello, Charles A., et al.
  Pubblicazione: (2016)
• Interleukin 37 is a fundamental inhibitor of innate immunity
  di: Nold, Marcel F, et al.
  Pubblicazione: (2010)
• Role for nuclear interleukin-37 in the suppression of innate immunity
  di: Li, Suzhao, et al.
  Pubblicazione: (2019)